JOHNSON & JOHNSON
JNJ
56 insider filings · Latest: Sep 8, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Feb 7, 2025 | Feb 7 6:27 PM | Wolk Joseph J | Proposed Sale | 13,015 | $153.89 | $2.0M | — | View → |
| Dec 4, 2024 | Dec 4 6:25 PM | Hait William | Proposed Sale | 25,742 | $149.90 | $3.9M | — | View → |
| Aug 30, 2024 | Aug 30 7:51 PM | Decker Robert J | Proposed Sale | 5,635 | $165.06 | $930.1K | — | View → |
← Previous
Page 3 of 3
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 15, 2026 | Feb 19 2:11 AM | Joaquin DuatoDirector, CEO and Chairman of the Board | Option Exercise | 8,187 | — | 9,008(D) | View → |
| Feb 13, 2026 | Feb 19 2:11 AM | Joaquin DuatoDirector, CEO and Chairman of the Board | Option Exercise | 76,523 | — | 0(D) | View → |
| Feb 15, 2026 | Feb 19 2:11 AM | Vanessa BroadhurstEVP, Global Corp Affairs | Grant/Award | 15,439 | $243.45 | 1,034(D) | View → |
| Feb 15, 2026 | Feb 19 2:11 AM | Vanessa BroadhurstEVP, Global Corp Affairs | Option Exercise | 1,018 | — | 1,050(D) | View → |
| Feb 13, 2026 | Feb 19 2:11 AM | Vanessa BroadhurstEVP, Global Corp Affairs | Option Exercise | 9,002 | — | 0(D) | View → |
| Feb 9, 2026 | Feb 12 1:47 AM | Joseph J WolkExec VP, CFO | Grant/Award | 37,463 | — | 37,463(D) | View → |
| Feb 9, 2026 | Feb 12 1:45 AM | Jennifer L TaubertEVP, WWC. Innovative Medicine | Grant/Award | 27,412 | — | 27,412(D) | View → |
| Feb 9, 2026 | Feb 12 1:43 AM | James D. SwansonEVP, CIO | Grant/Award | 9,412 | — | 9,412(D) | View → |
| Feb 9, 2026 | Feb 12 1:41 AM | Timothy SchmidEVP, WW Chair, MedTech | Grant/Award | 4,378 | — | 4,378(D) | View → |
| Feb 9, 2026 | Feb 12 1:39 AM | Kristen MulhollandEVP, Chief HR Officer | Grant/Award | 3,602 | — | 3,602(D) | View → |
| Feb 9, 2026 | Feb 12 1:37 AM | Elizabeth ForminardEVP, Chief Legal Officer | Grant/Award | 13,706 | — | 13,706(D) | View → |
| Feb 9, 2026 | Feb 12 1:34 AM | Joaquin DuatoDirector, CEO and Chairman of the Board | Grant/Award | 73,054 | — | 73,054(D) | View → |
| Feb 9, 2026 | Feb 12 1:33 AM | Robert J DeckerVP Corporate Controller | Grant/Award | 2,741 | — | 2,741(D) | View → |
| Feb 9, 2026 | Feb 12 1:28 AM | Kathryn E WengelEVP, Chief TO and Risk Officer | Grant/Award | 13,706 | — | 13,706(D) | View → |
| Feb 9, 2026 | Feb 12 1:24 AM | Vanessa BroadhurstEVP, Global Corp Affairs | Grant/Award | 8,594 | — | 8,594(D) | View → |
| Feb 6, 2026 | Feb 11 2:46 AM | Timothy SchmidEVP, WW Chair, MedTech | Option Exercise | 15,571 | $101.87 | 0(D) | View → |
| Feb 6, 2026 | Feb 10 12:42 AM | Kristen MulhollandEVP, Chief HR Officer | Option Exercise | 5,625 | $101.87 | 0(D) | View → |
| Feb 6, 2026 | Feb 10 12:40 AM | Kathryn E WengelEVP, Chief TO and Risk Officer | Option Exercise | 38,945 | $101.87 | 0(D) | View → |
| Feb 5, 2026 | Feb 6 10:46 PM | Elizabeth ForminardEVP, Chief Legal Officer | Option Exercise | 8,921 | $129.51 | 0(D) | View → |
← Previous
Page 4 of 4